Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 821-762-8 | CAS number: 4563-56-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Oral LD50 > 2000 mg/kg bw
RA from CAS 4259-15-8
Dermal LD50 > 5000 mg/kg bw
RA from CAS 4259-15-8
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- (non-GLP)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 232-296 g
- Housing: Housed individually in wire bottom cages
- Diet: ad libitum except overnight prior to dosing
- Water: ad libitum except overnight prior to dosing
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.1 - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Doses:
- 2200 mg/kg, 3300 mg/kg, 5000 mg/kg, 7500 mg/kg
- No. of animals per sex per dose:
- 10 male
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: 7 and 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross pathology including: thymus, heart, lungs, liver, kidneys, adrenal glands, spleen, gonads, gastro-intestinal tract, lymph nodes, pancreas, salivary glands, bladder, body fat, skeletal muscle, teeth, eyes and skin. - Statistics:
- Berkson, J. Biometrika, 44:411-435, 1957
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 3 100 mg/kg bw
- 95% CL:
- > 1 800 - < 5 100
- Mortality:
- 7500 mg/kg: 10/10 rats died 1-2 days after exposure
5000 mg/kg: 9/10 rats died between 1-9 days after exposure
3300 mg/kg: 6/10 rats died 1-2 days after exposure
2200 mg/kg: 2/10 rats died between 1-8 days after exposure - Clinical signs:
- Depresson, diarrhea, reduced food intake
- Gross pathology:
- Survivors had less than normal amounts of body fat. No other changes were observed.
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation(EC) No. 1272/2008
- Conclusions:
- CLP: not classified
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 03/02/1983 - 4/13/1983
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- (purity of the test material not given)
- Qualifier:
- according to guideline
- Guideline:
- other: Section 1500.3 – Federal Hazardous Substance Act Regulations – 16 CFR.
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: approx. 7 weeks of age
- Weight at study initiation: average weight between 200~300 g.
- Fasting period before study: Feed was withheld overnight prior to dosing.
- Housing: the animals were housed and maintained in accordance with standards set forth in the Guide for Care and Use of Laboratory Animals (DHEW publication No. 80-23). 5 rats/cage by sex.
- Diet: Wayne Lab-Blox, provided ad libitum.
- Water: tap water available ad libitum.
- Acclimation period: acclimated to the laboratory for an appropriate time prior to dosing.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18.3 - 22.8
- Humidity (%): 45 - 55
- Air changes: controlled environment, but no air change information provided.
- Photoperiod: 12 h light/dark cycle
IN-LIFE DATES: From: 03/02/1983 To: 04/13/1983. - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Doses:
- 2000 and 5000 mg/kg bw
- No. of animals per sex per dose:
- 5 /sex/dose
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: animals were observed frequently on the day of dosage and twice daily thereafter (morning and afternoon). Individual weights were recorded on the day of dosage, weekly thereafter and prior to sacrifice.
- Necropsy of survivors performed: gross necropsies were performed on all animals that either died during the 14 day observation period or on surviving animals that were sacrificed at the conclusion of the 14 day observation period. - Statistics:
- No data available.
- Preliminary study:
- Not applicable
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 - < 5 000 mg/kg bw
- Mortality:
- 5000 mg/kg
Male: Number of animals: 5; Number of deaths: 5
Female: Number of animals: 5; Number of deaths: 5
2000 mg/kg
Male: Number of animals: 5; Number of deaths: 0
Female: Number of animals: 5; Number of deaths: 1 - Clinical signs:
- All animals died in the high dose group.
In the low dose group, all animals appeared ruffled up to 24 h after treatment, but appeared normal thereafter.
In the low dose group, 1/5 female died on day 6; 2/5 females exhibited diarrhea, and 1/5 exhibited diarrhea and a hunched back. - Body weight:
- All animals showed body weight gain.
- Gross pathology:
- No gross abnormalities were noted in all animals (either found dead during the study or in the animals necropsied at the conclusion of the study).
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation(EC) No. 1272/2008
- Conclusions:
- CLP: not classified
- Executive summary:
In an acute oral toxicity study, 2 groups fasted Sprague-Dawley strain Albino rats (five male and five female) were given a single oral dose of undiluted test material at a dose level of 2000 and 5000 mg/kg bw and observed for 14 days.
All animals died in the high dose group. In the low dose group, all animals appeared ruffled up to 24 h after treatment, but appeared normal thereafter. In the low dose group, 1/5 female died on day 6; 2/5 females exhibited diarrhea, and 1/5 exhibited diarrhea and a hunched back. No gross abnormalities were noted in all animals (either found dead during the study or in the animals necropsied at the conclusion of the study). All animals showed expected body weight gain during the study period.
The oral LD50 value of test material in rats of both sexes has been determined to be greater than 2000 mg/kg body weight but less than 5000 mg/kg body weight.
Referenceopen allclose all
Table 1. Results
Dose Level (mg/kg) |
5000 |
2000 |
|||
Sex |
Male |
Female |
Male |
Female |
|
Average Body Weight (g) |
Initial |
243 |
211 |
219 |
209 |
7 d |
- |
- |
255 |
230 |
|
14 d |
- |
- |
315 |
258 |
|
Mortality (No. death/No. dosed) |
5/5 |
5/5 |
0/5 |
1/5 |
Table 2: Observations:
Sex |
Dose |
Time after dosing |
Observation |
Male |
2000 mg/kg |
4 h 24 h 48 h to 14 d |
5/5 appeared ruffled 5/5 appeared ruffled 5/5 appeared normal |
|
5000 mg/kg |
4 h 24 h 48 h |
5/5 appeared normal 3/5 found dead; 2/5 ruffled 2/5 found dead |
Female |
2000 mg/kg |
4 h 24 h 48 h
6 d 7 d to 14 d |
5/5 appeared ruffled 5/5 appeared ruffled 2/5 appeared normal, 2/5 exhibited diarrhea, 1/5 exhibited diarrhea and a hunched back 1/5 found dead; 4/5 appeared normal 4/5 appeared normal |
5000 mg/kg |
4 h 24 h 48 h |
5/5 appeared normal 4/5 found dead; 1/5 ruffled 1/5 found dead |
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Hazard assessment is conducted by means of read-across from a structural analogue/surrogate. The selected studies are the most adequate and reliable studies based on the identified similarities in structure and intrinsic properties between source and target substance and overall quality assessment (refer to the endpoint discussion for further details).
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1975
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- (occlusive)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 2.25-2.75 kg
- Housing: Housed individually in wire bottom cages
- Diet: approximately 4 ounces daily
- Water: ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.1 - Type of coverage:
- occlusive
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- % coverage: 100%
- Type of wrap if used: plastic sheet
REMOVAL OF TEST SUBSTANCE
- Time after start of exposure: test material removed 24 hours after exposure
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 5 g/kg bw - Duration of exposure:
- 24 h
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 6
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: 7 and 14 days
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross pathology including: thymus, heart, lungs, liver, kidneys, adrenal glands, spleen, gonads, gastro-intestinal tract, lymph nodes, pancreas, salivary glands, bladder, body fat, skeletal muscle, teeth, eyes and skin. - Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Mortality:
- One animal with abraded skin died 13 days after dosing
- Clinical signs:
- Severe erythema and edema noted at 24 hours. By seven days treated sites were thick and escharotic.
- Body weight:
- Treated animals weighed significantly less than controls.
Average body weight during study
Control: 2.47 kg (start), 2.49 kg (day 7), 2.85 kg (day 14
Treated: 2.44 kg (start), 2.15 kg (day 7), 2.15 kg (day 14)
Note: Values are an average of 6 rabbits except for day 14 treated, which is the mean of 5 animals - Gross pathology:
- Liver-like or necrotic-appearing areas of lung tissue observed in five rabbits. Further histology of the lungs revealed confluent bronchipneumonia or chronic interstitial pneumonia. Two rabbits had small white liver abscesses that were determined to be of parasitic origin after histological examination.
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation(EC) No. 1272/2008
- Conclusions:
- CLP: not classified
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- Hazard assessment is conducted by means of read-across from a structural analogue/surrogate. The selected study is the most adequate and reliable study based on the identified similarities in structure and intrinsic properties between source and target substance and overall quality assessment (refer to the endpoint discussion for further details).
Additional information
Justification for read-across
There are no reliable data available regarding acute toxicity forPhosphorodithioic acid, O,O-di-dodecyl-esters, zinc salts, neutral and basic(CAS 4563-56-8). Read-across from an appropriate substance Zinc bis[O,O-bis(2-ethylhexyl)] bis(dithiophosphate) (CAS 4259-15-8) is conducted in accordance with Regulation (EC) No 1907/2006, Annex XI, 1.5. in order to fulfil the standard data requirements defined in Regulation (EC) No 1907/2006, Annex VII, 8.5. Common functional groups, structural similarities and comparable toxicological properties of the source and target substance are the basis of read-across. A detailed justification for the analogue read-across approach is provided in the technical dossier (see IUCLID Section 13).
Acute oral toxicity: CAS 4259-15-8
A reliable acute toxicity study conducted with Zinc bis[O,O-bis(2-ethylhexyl)] bis(dithiophosphate) (CAS 4259-15-8) in male Sprague-Dawley rats similar to OECD Guideline 401 was available (WoE, 1975). In this study the test substance was orally administered by gavage at doses of 2200, 3300, 5000 and 7500 mg/kg bw, and thereafter observed for 14 days. Mortality was observed at all dose levels, at 2200 mg/kg bw 2/10 rats died, at 3300 mg/kg bw 6/10 rats died, at 5000 mg/kg bw 9/10 rats died and at 7500 mg/kg bw all animals died. In addition, clinical signs, such as depression and diarrhea, reduced food intake and lower body fat content were noted (not further specified). Based on the results of the conducted study, a LD50 of 3100 mg/kg bw was derived for male rats.
In a second reliable acute oral toxicity study a single dose of the undiluted test material Zinc bis[O,O-bis(2-ethylhexyl)] bis(dithiophosphate) (CAS 4259-15-8) was administered by gavage to ten fasted rats (5 males and 5 females) at each treatment level 2500 or 5000 mg/kg bw and observed for 14 days according to Section 1500.3 and under GLP (WoE, 1983). All animals died in the high dose group. In the low dose group, all animals appeared ruffled up to 24 h after treatment, but appeared normal thereafter. In the low dose group, 1/5 female died on day 6; 2/5 females exhibited diarrhea, and 1/5 exhibited diarrhea and a hunched back. No gross abnormalities were noted in all animals (either found dead during the study or in the animals necropsied at the conclusion of the study). All animals showed expected body weight gain during the study period. The oral LD50 value of test material in rats of both sexes has been determined to be greater than 2000 mg/kg bw but less than 5000 mg/kg bw.
Acute dermal toxicity: CAS 4259-15-8
In an acute dermal toxicity study conducted similar to OECD 402 6 male rabbits were exposed to undiluted Zinc bis[O,O-bis(2-ethylhexyl)] bis(dithiophosphate) (CAS 4259-15-8) at a dose level of 5000 mg/kg bw under occlusive conditions (Bullock, 1975). The fur of all rabbits was clipped one day prior to testing. 3/6 rabbits were further prepared by abrading the skin with a hypodermic needle. The animals were observed 14 days for signs of systemic toxicity and mortality. 1/3 rabbits with abraded skin died 13 days after dosing. Severe erythema and edema were noted at 24 hours. By seven days treated sites were thick and escharotic. Liver-like or necrotic-appearing areas of lung tissue observed in five rabbits. Further histology of the lungs revealed confluent bronchopneumonia or chronic interstitial pneumonia. Two rabbits had small white liver abscesses that were determined to be of parasitic origin after histological examination. Based on the results of the conducted study, the LD50 was derived to be > 5000 mg/kg bw.
Justification for classification or non-classification
Applying the RA-approach, the available data on acute oral and dermal toxicity do not meet the criteria for classification according to Regulation (EC) 1272/2008 and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.